Ford Robert B

USNatural personCEO

Insider

Ford Robert B

USNatural personCEO

Transactions

139

Issuers

Buys / Sells

6/49

Last tx

27 Feb 2026

Behaviour

1 purchase reported after at least 12 months of silence — most recent on 23 Jan 2026.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
ABBOTT LABORATORIES	306,461	reported	27 Feb 2026	tx 140+4,858,934−1,650,817

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
27 Feb 2026	TAX_WITHHOLDING	ABBOTT LABORATORIES	30,308	116.26 USD
24 Feb 2026	GRANT_AWARD	ABBOTT LABORATORIES	83,464	0.00 USD
24 Feb 2026	GRANT_AWARD	ABBOTT LABORATORIES	344,066	0.00 USD	deriv
23 Jan 2026	PURCHASE	ABBOTT LABORATORIES	18,800	107.13 USD	first after silence

InsiderLens aggregates public information issued by financial regulators (SEC, AMF, FCA, BaFin, AFM, FI, HKEX, ASX). The service constitutes neither investment advice nor a recommendation to buy or sell. Past performance is no guarantee of future results. Investing in financial instruments carries the risk of capital loss.

Current positions

Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.

Issuer	Shares	Source	Last tx	Detail
ABBOTT LABORATORIES	306,461	reported	27 Feb 2026	tx 140+4,858,934−1,650,817

Recent transactions

Date	Type	Issuer	Qty	Price	Signals
27 Feb 2026	TAX_WITHHOLDING	ABBOTT LABORATORIES	30,308	116.26 USD
24 Feb 2026	GRANT_AWARD	ABBOTT LABORATORIES	83,464	0.00 USD
24 Feb 2026	GRANT_AWARD	ABBOTT LABORATORIES	344,066	0.00 USD	deriv
23 Jan 2026	PURCHASE	ABBOTT LABORATORIES	18,800	107.13 USD	first after silence